Advertisement

Aesthetic Plastic Surgery

, Volume 37, Issue 1, pp 91–94 | Cite as

Ruptured Poly-Implant Protheses Breast Implant After Aesthetic Breast Augmentation: Diagnosis, Case Management, and Histologic Evaluation

  • M. Dieterich
  • J. Stubert
  • A. Stachs
  • A. Radke
  • T. Reimer
  • B. Gerber
Case Report Breast

Abstract

Since the scandal of the poly-implant protheses (PIP) breast implants, all patients with PIP are advised to have their implants removed. With approximately 400,000 PIP implants sold worldwide breast, surgeons will be confronted with these patients. Histologic examination in the reported case showed silicone infiltration into fatty tissue and breast tissue without signs of malignancy. A general histologic analysis for the rare event of an anaplastic large T cell lymphoma is not advised. The malignant potential of PIP implants currently is uncertain, and further investigation is required.

Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

Keywords

Breast implants Histology PIP Rupture Surgery 

Notes

Acknowledgments

The authors thank Prof. Dr. Med. Werner Audretsch for his critical comments and advice as well as Peter Koerfgen for his English proofreading.

References

  1. 1.
    SCENIHR (scientific committee on emerging and newly identified health risks), European commission, press release, medical devices: European commission asks for further scientific study and draws first lessons from the recent fraud on breast implants, 2 Feb 2012Google Scholar
  2. 2.
    Spear SL, Murphy DK, Slicton A, Walker PS (2007) Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg 120(7 Suppl 1):8S–16S, discussion 17S–18SGoogle Scholar
  3. 3.
    Bengtson BP, Van Natta BW, Murphy DK, Slicton A, Maxwell GP (2007) Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast Reconstr Surg 120(7 Suppl 1):40S–48S. doi: 10.1097/01.prs.0000286666.29101.11 PubMedGoogle Scholar
  4. 4.
    AWOgyn (2012) Working group of the german society of obsetrics and gynecology for plastic, aesthetic and reconstructive surgery in gynecology (AWOgyn). www.awogyn.org. Accessed April 2012
  5. 5.
    Update of recommendations for women with silicone filled poly implant prosthesis (PIP) breast implants (Presseerklärung französisches Gesundheitsministerium). http://www.afasssaps.fr/Afsssaps-media/Publications Accessed 23 December 2011
  6. 6.
    Poly implant prothèse (PIP) breast implants: Joint surgical statement on clinical guidance for patients, GPs and surgeons; The Association of Breast Surgery, the British Association of Plastic and Reconstructive Aesthetic Surgeons, the British Association of Aesthetic Plastic Surgeons, the Federation of Surgical Speciality Associations and the Royal College of Surgeons; first published on 6 January 2012. http://www.rcseng.ac.uk/publications/docs/pip-statement/ Accessed June 2012
  7. 7.
    Poly implant prothese (Pip) breast implants: final report of the expert group, Sir Bruce Keogh, NHS Medical Director, June 2012. http://www.nhs.uk/conditions/breast-implants/documents/PIP%20expert%20group%20final%20report.pdf
  8. 8.
    SCENIHR (scientific committee on emerging and newly identified health risks), European Commission, The safety of PIP silicone breast implants, version of 1st February 2012. Accessed April 2012Google Scholar
  9. 9.
    Maijers MC, Niessen FB (2012) Prevalence of rupture in poly implant prothese silicone breast implants, recalled from the European market in 2010. Plast Reconstr Surg 129(6):1372–1378. doi: 10.1097/PRS.0b013e31824f0108 PubMedCrossRefGoogle Scholar
  10. 10.
    Berry M, Stanek JJ (2012) The PIP mammary prosthesis: a product recall study. J Plast Reconstr Aesthet Surg 65(6):697–704. doi: 10.1016/j.bjps.2012.02.019 PubMedCrossRefGoogle Scholar
  11. 11.
    Breast implants with silicone based gel filling from poly implant prosthese company: update of test results. Agence Francaise de Securite Sanitaire des Produits de Sante. http://www.afssaps.fr/Afssaps-media/Publications Accessed 14 April 2011
  12. 12.
    Smith TJ, Ramsaroop R (2012) Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion. Breast 21(1):102–104. doi: 10.1016/j.breast.2011.07.007 PubMedCrossRefGoogle Scholar
  13. 13.
    Jewell M, Spear SL, Largent J, Oefelein MG, Adams WP Jr. (2011) Anaplastic large T-cell lymphoma and breast implants: a review of the literature. Plast Reconstr Surg 128(3):651–661. doi: 10.1097/PRS.0b013e318221db8100006534-201109000-00004 PubMedCrossRefGoogle Scholar
  14. 14.
    Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B (2000) CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96(12):3681–3695PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York and International Society of Aesthetic Plastic Surgery 2013

Authors and Affiliations

  • M. Dieterich
    • 1
  • J. Stubert
    • 1
    • 2
  • A. Stachs
    • 1
  • A. Radke
    • 3
  • T. Reimer
    • 1
  • B. Gerber
    • 1
  1. 1.Breast Unit, Department of Obstetrics and GynecologyUniversity of RostockRostockGermany
  2. 2.Research Laboratory, Department of Obstetrics and GynecologyUniversity of RostockRostockGermany
  3. 3.Institute of PathologyHospital SuedstadtRostockGermany

Personalised recommendations